Inventor · disambiguated record
James H. Holms
Also filed as: HOLMS JAMES H · HOLMS James
20 granted patents·17 pending applications·363 citations·filing 1988–2024
95Inventor score
Top patents by PatentIndex Score
37 records- 0197US6294573B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted Sep 25, 2001·131 cites·17 claims
- 0288US4992464AHeteroaryl N-hydroxy amides and ureas with polar substituents as 5-lipoxygenase inhibitorsABBOTT LAB·Filed 1989·Granted Feb 12, 1991·26 cites·3 claims
- 0388US2025152600A1Bromodomain inhibitorsABBVIE INC·Filed 2024·Application pending·0 cites
- 0487US9296741B2Bromodomain inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·7 cites·61 claims
- 0584US5112848AFuran and pyrrole containing lipoxygenase inhibiting compoundsABBOTT LAB·Filed 1988·Granted May 12, 1992·38 cites·10 claims
- 0683US5952320AMacrocyclic inhibitors of matrix metalloproteinases and TNFα secretionABBOTT LAB·Filed 1997·Granted Sep 14, 1999·34 cites·13 claims
- 0783US5124342A4-hydroxythiazoles as 5-lipoxygenase inhibitorsABBOTT LAB·Filed 1990·Granted Jun 23, 1992·53 cites·3 claims
- 0880US2023158039A1Bromodomain inhibitorsABBVIE INC·Filed 2022·Application pending·0 cites
- 0979US9957263B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted May 1, 2018·3 cites·5 claims
- 1078US10035800B2Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jul 31, 2018·3 cites·48 claims
- 1177US9561231B2Pyridinone and pyridazinone derivativesABBVIE INC·Filed 2013·Granted Feb 7, 2017·4 cites·43 claims
- 1277US9321764B2Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2014·Granted Apr 26, 2016·3 cites·25 claims
- 1377US7468371B2Tricyclic pyrazole kinase inhibitorsABBOTT LAB·Filed 2005·Granted Dec 23, 2008·4 cites·20 claims
- 1475US10131657B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 20, 2018·2 cites·14 claims
- 1572US5026729ALipoxygenase inhibiting compoundsABBOTT LAB·Filed 1989·Granted Jun 25, 1991·10 cites·6 claims
- 1672US2021236508A1Bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 1770US2021070756A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 1869US2010076051A1Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2009·Application pending·0 cites
- 1968US2020291027A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2020·Application pending·0 cites
- 2067US8435980B2Pyrrolopyridine inhibitors of kinasesFLORJANCIC ALAN S·Filed 2010·Granted May 7, 2013·2 cites·15 claims
- 2166US5665777ABiphenyl hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 1995·Granted Sep 9, 1997·24 cites·14 claims
- 2265US2018296566A1Bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 2364US5985911AC-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretionABBOTT LAB·Filed 1997·Granted Nov 16, 1999·10 cites·13 claims
- 2463US2019389861A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 2561US7129260B2Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2004·Granted Oct 31, 2006·1 cites·15 claims
- 2661US2018298003A1Tetracyclic bromodomain inhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 2758US2016143916A1Bromodomain inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 2856US2019084981A1Bromodomain InhibitorsABBVIE INC·Filed 2018·Application pending·0 cites
- 2955US8436179B2Kinase inhibitor with improved solubility profileMICHAELIDES MICHAEL R·Filed 2012·Granted May 7, 2013·0 cites·2 claims
- 3051US2006287370A1Isoindolinone kinase inhibitorsCURTIN MICHAEL L·Filed 2006·Application pending·0 cites
- 3149US5459152APlatelet activating factor antagonistsABBOTT LAB·Filed 1992·Granted Oct 17, 1995·8 cites·7 claims
- 3247US2007135387A1Inhibitors of protein kinasesMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 3344US2016237084A1Dihydro-pyrrolopyridinone inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3440US2006025383A1Aminobenzoxazoles as therapeutic agentsWISHART NEIL·Filed 2005·Application pending·0 cites
- 3539US2002007060A1Reverse hydroxamate inhibitors of matrix metalloproteinasesFiled 2001·Application pending·0 cites
- 3639US2002177594A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 3737US8293738B2Indazole inhibitors of kinaseMICHAELIDES MICHAEL R·Filed 2011·Granted Oct 23, 2012·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when James H. Holms files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →